NCT01720095 Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis Status COMPLETED Phase PHASE3
NCT01579422 Social Cognitive Training for Psychosis: Treatment Development Status COMPLETED Phase PHASE1
NCT01565174 The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis Status UNKNOWN Phase N/A
NCT01511406 Cognitive Behavioral Therapy for Patients With an Early Psychosis Status COMPLETED Phase PHASE2
NCT01492439 Effectiveness of Cognitive Remediation in a Supported Education Setting Status COMPLETED Phase NA
NCT01487291 Prevalence of Clinical and Laboratory Markers of Hypofibrinolysis in Psychotic Patients Status COMPLETED Phase N/A
NCT01436331 A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early Psychosis Status COMPLETED Phase NA
NCT01399112 A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis Status COMPLETED Phase NA
NCT01396850 Measurments Of BBB Breakdown In The Pathogenesis Of Psychiatric Disorders Status UNKNOWN Phase N/A
NCT01364818 Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment Status COMPLETED Phase N/A
NCT01216891 Multi-disciplinary Treatment for Patients Experiencing First Episode of Psychosis Status COMPLETED Phase NA
NCT01161277 Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning Status COMPLETED Phase PHASE4
NCT01127503 Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome Status TERMINATED Phase PHASE2
NCT01119638 Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone Status COMPLETED Phase PHASE4